World Drug Safety Congress Europe, 2024

We are looking forward to exhibiting at the World Drug Safety Congress Europe 2024, Oct 09-10, 2024!

Visit our booth #76 and speak with our experts – Dr. Frank Laschewski, Qualified Person for Pharmacovigilance (QPPV) and Dr. Kanwalpreet Kaur, QPPV & Head of Strategic Development Group to explore how our comprehensive End-to-End Pharmacovigilance Services, leveraging smart integrated processes, can enhance patient safety and provide effective solutions.  Please click here to schedule a meeting with our experts.

We are also excited to host a speaking session by Dr. Kanwalpreet Kaur, QPPV & Head of Strategic Development Group on:

Topic: Developing risk management plans for cell and gene therapies

October 10, 2024, 12.45pm CEST

About WDSC

The World Drug Safety Congress is one of the largest conferences attended by key players across the pharma industry. It brings together more than 1500+ key thought leaders from Biopharma companies to explore challenges within pharmacovigilance. This year, WDSC focuses on addressing key challenges and use of big data, AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches. The conference will bridge the gap between international regulatory bodies, industry professionals and patient representatives, bringing key actors and across industries and geographical regions.